4.7 Article

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study

Yajing Huang et al.

Summary: This study explored the relationship between C-peptide levels and glycemic control as well as diabetic complications in patients with type 2 diabetes mellitus (T2DM). The results showed that higher C-peptide levels were associated with better glycemic control and lower incidence of diabetic kidney disease (DKD) and diabetic retinopathy (DR). However, the effects of C-peptide on DKD and DR were different, with C-peptide promoting the incidence of DKD but protecting against DR. Additionally, a higher ratio of postprandial C-peptide to fasting C-peptide was important for achieving glycemic control but did not reduce the risk of DKD, DR, and fatty liver.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Article Endocrinology & Metabolism

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings

Katarzyna Dziopa et al.

Summary: This study aimed to compare the performance of risk prediction scores for cardiovascular disease (CVD) in individuals with type 2 diabetes. The Systemic Coronary Risk Evaluation (SCORE) CVD rule derived in the general population performed best for both CVD and a broader definition of CVD. Simple recalibration considerably improved the performance of the scores.

DIABETOLOGIA (2022)

Article Medicine, General & Internal

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study

Shona J. Livingstone et al.

Summary: This study aimed to develop and validate a competing risk model (CRISK) to predict incident cardiovascular disease (CVD) and compare its performance with QRISK3. The study found that CRISK and CRISK-CCI performed better than QRISK3, with CRISK-CCI recommending fewer individuals for treatment and having a lower number needed to treat (NNT) to prevent a new CVD event. Therefore, it is recommended to use competing risk models for primary prevention treatment recommendations for CVD.

BMC MEDICINE (2022)

Article Endocrinology & Metabolism

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study

Martin B. Whyte et al.

Summary: Early control of HbA1c improves cardiovascular outcomes in patients with type 2 diabetes, but subsequent glycaemic variability increases the risk for individuals.

DIABETES OBESITY & METABOLISM (2022)

Article Rheumatology

QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus

Juan Carlos Quevedo-Abeledo et al.

Summary: The study compared the predictive capacity of QRISK3 and SCORE for subclinical carotid atherosclerosis in patients with SLE, finding that QRISK3 had a higher discrimination capacity than SCORE.

RHEUMATOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study

Haibin Li et al.

Summary: The study found that higher baseline and mean TyG index as well as greater TyG index variability were each independently associated with a higher incidence of cardiovascular disease.

CARDIOVASCULAR DIABETOLOGY (2022)

Review Public, Environmental & Occupational Health

Cardiovascular disease risk prediction models in the Chinese population- a systematic review and meta-analysis

Guo Zhiting et al.

Summary: This study systematically reviewed the cardiovascular disease (CVD) risk prediction models derived and/or validated in the Chinese population. The usefulness of most models remains unclear due to incomplete external validation and head-to-head comparison. Future research should focus on externally validating or tailoring these models to local settings.

BMC PUBLIC HEALTH (2022)

Article Cardiac & Cardiovascular Systems

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes

Shi Tai et al.

Summary: The TyG index can serve as a predictive marker for cardiovascular events in patients with type 2 diabetes mellitus, and long-term monitoring of this index can assist in risk stratification and outcome prediction.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus

George C. Drosos et al.

Summary: The study aimed to evaluate the performance of eight clinical risk prediction scores in identifying SLE patients at high cardiovascular disease risk defined by atherosclerotic plaques. Results showed that most of the generic and SLE-adapted risk scores underestimated high CVD risk in patients with SLE.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Article Clinical Neurology

The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis

Martina Petruzzo et al.

Summary: The study found an association between cardiovascular risk factors and the prognosis of multiple sclerosis (MS). An increase in the Framingham risk score was associated with higher risks of MS relapses, disability, and treatment escalation. Early identification and management of cardiovascular comorbidities should be considered in MS management.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Rheumatology

Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis

Alfonso Corrales et al.

Summary: The combination of QRISK3 and EULAR mSCORE allows for the identification of most RA patients at high risk of carotid plaques.

RHEUMATOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies

Xiaobo Ding et al.

Summary: This meta-analysis found that a higher TyG index is independently associated with an increased incidence of ASCVDs, CAD, and stroke in individuals without ASCVDs at baseline. Subgroup analyses suggested no significant impact of age, sex, or diabetic status on this association.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Rheumatology

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus

Jagan Sivakumaran et al.

Summary: This study compared the performance of different cardiovascular risk prediction tools in predicting cardiovascular disease in patients with Systemic Lupus Erythematosus (SLE). The results showed that modified Framingham Risk Score (mFRS) outperformed other tools, while SLE Cardiovascular Risk Equation (SLECRE) had the highest sensitivity but lowest specificity. Further research is needed to develop more accurate risk prediction tools for this population.

LUPUS SCIENCE & MEDICINE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients

Javad Alizargar et al.

CARDIOVASCULAR DIABETOLOGY (2020)

Article Medicine, General & Internal

Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations

Dennis T. Ko et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

Review Urology & Nephrology

Genetics of diabetes mellitus and diabetes complications

Joanne B. Cole et al.

NATURE REVIEWS NEPHROLOGY (2020)

Review Cardiac & Cardiovascular Systems

Epidemiology of Diabetes Mellitus and Cardiovascular Disease

Diana Glovaci et al.

CURRENT CARDIOLOGY REPORTS (2019)

Article Endocrinology & Metabolism

Elevated TyG Index Predicts Progression of Coronary Artery Calcification

Kahui Park et al.

DIABETES CARE (2019)

Article Cardiac & Cardiovascular Systems

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

Elisa Dal Canto et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)

Article Endocrinology & Metabolism

Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019

William T. Cefalu et al.

DIABETES CARE (2019)

Article Endocrinology & Metabolism

Pathogenesis of Cardiovascular Disease in Diabetes

Andrea V. Haas et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)

Review Medicine, General & Internal

Prediction models for cardiovascular disease risk in the general population: systematic review

Johanna A. A. G. Damen et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Medicine, General & Internal

Prediction models for cardiovascular disease risk in the general population: systematic review

Johanna A. A. G. Damen et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

Sreenivasa Rao Kondapally Seshasai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

General cardiovascular risk profile for use in primary care - The Framingham Heart Study

Ralph B. D'Agostino et al.

CIRCULATION (2008)